Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 388–390 | Cite as

Accelerated repigmentation of vitiligo after an irritant reaction following occlusion dressing with topical tacrolimus

  • Hyun Jeong Ju
  • Ji Hye Lee
  • Gyong Moon Kim
  • Chul Jong Park
  • Jung Min Bae
Correspondence
  • 5 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol 2003; 139: 571–4;discussion:3.CrossRefPubMedGoogle Scholar
  2. 2.
    Sisti A, Sisti G, Oranges CM. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo:a comprehensive literature review. An Bras Dermatol 2016; 91: 187–95.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bae JM, Hong BY, Lee JH, Lee JH, Kim GM. The efficacy of 308–nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo:a systematic review and metaanalysis of randomized controlled trials (RCTs). J Am Acad Dermatol 2016; 74: 907–15.CrossRefPubMedGoogle Scholar
  4. 4.
    Grimes PE, Morris R, Avaniss–Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo:therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004; 51: 52–61.CrossRefPubMedGoogle Scholar
  5. 5.
    Tjioe M, Vissers WH, Gerritsen MJ. Topical macrolide immunomodulators:a role in the treatment of vitiligo? Am J Clin Dermatol 2006; 7: 7–12.CrossRefPubMedGoogle Scholar
  6. 6.
    Lan CC, Wu CS, Chen GS, Yu HS. FK506 (tacrolimus) and endothelin combined treatment induces mobility of melanoblasts:new insights into follicular vitiligo repigmentation induced by topical tacrolimus on sun–exposed skin. Br J Dermatol 2011; 164: 490–6.PubMedGoogle Scholar
  7. 7.
    Hartmann A, Brocker EB, Hamm H. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion. J Dtsch Dermatol Ges 2008; 6: 383–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Fuchs M, Schliemann–Willers S, Heinemann C, Elsner P. Tacrolimus enhances irritation in a 5–day human irritancy in vivo model. Contact Dermatitis 2002; 46: 290–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Stander S, Stander H, Seeliger S, Luger TA, Steinhoff M. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 2007; 156: 1020–6.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Hyun Jeong Ju
    • 1
    • 2
  • Ji Hye Lee
    • 1
  • Gyong Moon Kim
    • 1
  • Chul Jong Park
    • 2
  • Jung Min Bae
    • 1
  1. 1.Department of Dermatology, St. Vincent’s Hospital, College of MedicineThe Catholic University of KoreaSuwonKorea
  2. 2.Department of Dermatology, Bucheon St. Mary’s Hospital, College of MedicineThe Catholic University of KoreaBucheonKorea

Personalised recommendations